A B S T R A C T Acute iron loading of rats, by intraperitoneal administration of iron-dextran (500 mg Fe/kg body wt 18-20 h before killing) decreased by 30% the rate of conversion of 5-amino-['4Cllevulinate (['4C]ALA) into heme as measured with a recently described procedure for liver homogenates (1981. Biochem. J. 198: 595-604). The decrease in conversion of labeled ALA into heme caused by iron loading was shown to be due to a 70-80% decrease in activity of ALA dehydrase. The decrease in activity of ALA dehydrase caused by iron loading was not associated with a decrease in hepatic concentrations of GSH, nor could it be reversed by addition of dithiothreitol, Zn2+ or chelators of Fe2+ and Fe3'. Addition of FeSO4, ferric citrate, or ferritin to homogenates of control liver had no effect of activity of ALA dehydrase. The decrease in activity of ALA dehydrase, caused by iron-dextran, was mirrored by a reciprocal increase in ALA synthase. Iron-dextran potentiated the induction of ALA synthase by allylisopropylacetamide. However, this potentiation could be dissociated from the decrease in ALA dehydrase caused by iron loading.
INTRODUCTION
After administration of a single dose of iron-dextran to rats, there is a transient increase in activity of he-A portion of this work has appeared in abstract form in 1981. Hepatology. 1: 497. Address reprint requests to Dr. Bonkowsky, Veterans Administration Medical Center.
patic 5-aminolevulinate (ALA)' synthase, the rate-limiting enzyme in hepatic heme biosynthesis (1) . The peak of the increase (four-to sixfold above control) occurs 12-24 h after treatment; by 48 h the activity of ALA synthase decreases to 1.5-fold greater than control, and persists for several weeks (1, 2) . According to current concepts, a regulatory heme pool exerts endproduct negative feedback control on synthesis of ALA synthase (for recent reviews, see refs. [3] [4] [5] . Decreases in this heme pool may arise as the result of enhanced heme breakdown or of decreased heme synthesis. It has been proposed by some investigators that iron decreases hepatic heme synthesis by inhibiting uroporphyrinogen decarboxylase (6) . However, others have reported no effect (7) or activation (8) of the decarboxylase by ionic iron. We have also failed to find evidence for a decrease in activity of uroporphyrinogen decarboxylase in iron-loaded liver (1, 9) .
In this paper, we use a procedure recently developed by our laboratory (10) to show that the rate of heme synthesis from ALA is diminished in liver homogenates of iron-loaded rats. We further show that the decrease can be-accounted for by a decrease in activity of ALA- dehydrase that occurs in iron-loaded livers.
METHODS
Animals and preparation of liver homogenates. Male Sprague-Dawley rats (150-200 g) were kept as previously described (11) and starved 24 h before killing. Rats treated with iron-dextran >24 h before killing were starved 16 h before injection with iron-dextran, refed after injection, and starved again 24 h before killing. All controls received dextran-5 (2 g/kg) in normal saline (200 mg/ml). Both irondextran and dextran-5 were tolerated well as reported previously (1) .
Rats were killed by decapitation and their livers quickly removed, weighed, and homogenized (20% wt/vol) in icecold 0. 25 and heme precursors, and the extraction of unconjugated bilirubin were performed as described earlier (10) . We measured malondialdehyde (MDA) by the method of Buege and Aust (12) .
Activities of ALA dehydrase were routinely measured in 7.7% (wt/vol) homogenates containing ALA (5 mM), dithiothreitol (DTT) (10 mM), and BHT (45 uM). DTT was sometimes omitted, as described in Results. Tubes containing a total volume of 0.65 ml were incubated for 30 min at 370C in a shaking water bath. We stopped the reaction by placing the tubes in a slurry of water and ice and added 2 vol of 7.5% TCA:0.05 M HgCl2 with mixing. After centrifugation (1,000 g, 10 minm) we mixed 1 ml of supernatant with 1 ml modified Ehrlich's reagent (13) , and after 15-25 min, scanned the mixture from 500-680 nm against a "blank" using an Aminco DW2 Spectrophotometer (American Instrument Co., Silver Springs, MD). The "blank" consisted of homogenate to which TCA had been added at zero time and that had been kept on ice for 30 min. We calculated porphobilinogen concentrations using a A/(555-650 nm) of 61,000 (13) .
Activities of uroporphyrinogen decarboxylase were measured in 20% (wt/vol) homogenates by determining the rate of decarboxylation of pentacarboxylate porphyrinogen III to coproporphyrinogen III (14) . Use of BHT as antioxidant. In previous studies, FeSO4, in the presence of the antioxidant menadione, increased the rate of formation of heme from ALA by homogenates of rat liver, although menadione alone decreased the rate of conversion of ALA into heme (10 could only contribute a small fraction of the change observed.
Is decreased heme radioactivity due to a decreased rate of synthesis of heme or heme precursors? The elimination of (a) and (b) coupled together with data of Table I imply there is a decreased rate of synthesis of labeled heme and heme precursors from ['4C]ALA in homogenates of iron-loaded rats. Previously, it had been found that administration of ferric citrate (16) or iron-dextran (17) to rats decreased activity of ALA dehydrase. Therefore, we made further studies of the effect of iron-loading on this enzyme, particularly on the time sequence and on heme synthesis in vitro.
Effect of iron loading on hepatic ALA dehydrase Iron loading produced a marked decrease in activity of ALA dehydrase that was mirrored by a reciprocal increase in ALA synthase (Fig. 2a) . A transient decrease in activity of ALA dehydrase was observed after iron loading, in five separate experiments, although there was some variability in the maximal degree of the decrease (50-80%) and the time after iron treatment at which the nadir occurred (12-20 h).
Kinetics of ALA dehydrase in iron-loaded livers. The major effect of iron loading on ALA-dehydrase was to decrease the maximum velocity (Vmax) (At 18 h, control = 1,600 nmol porphobilinogen (PBG)/g liver/h; iron-loaded = 394 nmol PBG/g liver per h). (Fig. 2b) . Second, omission of DTT from the assay for ALA dehydrase produced only a 10-15% decrease in activity in homogenates of both control and iron-loaded livers. (b) ALA dehydrase also requires Zn21 for activity (18); thus we tested the effect of the addition of Zn21 (0.1-1.0 mM) with or without 20 min of preincubation, on activity of the enzyme in homogenates of iron-loaded liver. When added to liver homogenates from control rats or from rats treated with iron-dextran, Zn2+ either had no effect (at 0.1 mM) or decreased activity by 50% (at 0.5 mM) or 80% (at 1.0 mM). (c) Another possibility is that some iron compound inhibits ALA dehydrase directly. We investigated this possibility in rat liver homogenates in vitro, by adding either different iron compounds to control homogenates or chelators of iron to homogenates from rats treated with iron dextran. FeSO4, iron-dextran, ferric citrate or ferritin (each at 0.25, 1.5, and 5 mM Fe) had no appreciable effect on activity of the dehydrase in homogenates of control rat liver. (The concentration of iron in 10% homogenate of iron-loaded liver 18-24 h after treatment is -1 mNI). When liver homogenates from rats treated with iron-dextran 12 or 18 h before killing were treated with desferrioxamine (7 mnM), a chelator of Fe"+ (19) , ferrozine (0.25 mM), a chelator of Fe 2 (20) , or a combination of the two, there was no increase in activity of ALA dehydrase. At these or lower concentrations, the chelators alone did not affect activity of ALA dehydrase in homogenates of control livers. (Concentrations of ferrozine >0.25 mM decreased activity of dehydrase in homogenates of control livers.) (d) The decrease in dehydrase activity in homogenates of ironloaded livers could not be attributed to iron-catalyzed lipid peroxidation in vitro since addition of BHT to the assay, which totally prevented formation of malonaldehyde, had no effect upon dehydrase activity. Also, the addition of iron salts, with or without BHT, to homogenates of control liver had no effect on activity of ALA dehydrase, regardless of iron-catalyzed lipid peroxidation. ( Fig.   3 . The percent decrease in ALA dehydrase was always much greater than the decrease in accumulation of radioactivity. As shown in Fig. 3 The kinetics of the incorporation of ALA into 2(protoporphyrin + heme) were determined using homogenates of control and iron-loaded livers. The activity of ALA dehydrase in the homogenate of the ironloaded liver was decreased by 75%. The concentration of ALA needed to achieve half-maximal rates of formation of 2(protoporphyrin + heme) was increased from 5 ,uM (control) to 9 FM (iron-loaded).
The inhibition of l(protoporphyrin + heme) in Fig.  3 was obtained using an initial concentration of 40 ,M ALA and 30-min incubations. Decreasing the initial concentration of ALA to 5 ,M increased the inhibition of heme synthesis, whereas increasing the initial concentration of ALA to 100 FM decreased the inhibition (Table 1II) . Also, the inhibition of heme formation was greater for all concentrations of ALA when the incubations were stopped at 5 min. These results indicate that there is a lag in the production of labeled heme, which probably is due to lag in PBG synthesis.
We next looked for evidence of inhibition of other steps of the pathway between ALA and heme. Homogenates of control and iron-loaded liver were incubated for 1 h with a high concentration of unlabeled ALA (1 mM), and the amount and type of porphyrins that accumulated were measured. In this study, we Homogenates from rats described in Fig. 4 were incubated in the presence of FeSO4 (0.25 mM) and BHT (45 MAM) with three concentrations of [14C]ALA. Heme was extracted from the samples and counted as described in Methods. For ease of comparison, the accumulation of label in heme by homogenate of iron-loaded liver is presented as a fraction of that by homogenate of control liver.
added FeSO4 (0.25 mM) to control homogenate to provide optimal substrate for ferrochelatase (10) . Addition of FeSO4 to iron-loaded homogenate did not enhance accumulation of labeled heme. Both kinds of homogenate accumulated similar amounts of porphyrin, 0.8 nmol/g of uro-plus coproporphyrin, and 2.0 nmol/g of protoporphyrin. Thus, iron loading does not cause accumulation of heme precursors in the biosynthetic pathway leading to protoporphyrin. Furthermore, treatment of rats with iron-dextran had no effect on activity of hepatic uroporphyrinogen decarboxylase, measured 4 and 18 h after treatment (results not shown).
Effect of iron-dextran, AIA, and the combination on activities of hepatic ALA synthase, ALA dehydrase, and uroporphyrinogen decarboxylase
Administration of ferric citrate (9, 16) or iron-dextran (1) to rats potentiates the induction of hepatic ALA synthase produced by the porphyrogenic chemical AIA. To test whether this potentiation by iron is related to a decrease in activity of ALA dehydrase, or uroporphyrinogen decarboxylase, we performed experiments of the type summarized in Fig. 4 . AIA, given simultaneously with iron-dextran, prevented the decrease in activity of ALA dehydrase produced by irondextran alone (Fig. 4b, 18 h time point) . AIA treatment, with or without iron-dextran, did not affect hepatic uroporphyrinogen decarboxylase measured 4 and 18 h after treatment (results not shown). Thus, iron- (Fig. 3) . The cause of the transient decrease in activity of ALA dehydrase mediated in vivo by iron treatment remains unknown. We could find no evidence that it was due (a) to direct action of either some iron compound or other soluble inhibitor; (b) to iron-catalyzed lipid peroxidation in vitro; (c) to depletion of GSH in vivo; or (d) to a deficiency of zinc. Our inability to inhibit ALA dehydrase in vitro with ferric citrate differs from previous findings (16) possibly because of the different assay methods used.
The decrease in activity of ALA dehydrase caused by iron loading was rapid and transient (Fig. 2a) . If the half-life of the dehydrase molecules in normal rat liver is similar to the half-life of the mouse liver enzyme (5-6 d) (23), our results imply either that acute iron loading increases the catabolism of the dehydrase molecules, or that iron loading decreases the activity of the dehydrase molecules. The effect is short lived (Fig. 2a) despite the fact that the concentration of iron within the liver continued to increase (Fig. 2b) . These findings provide additional support for the transient occurrence of an "active" pool of iron (1) .
Effect of decreased activity of ALA dehydrase on hepatic heme synthesis. Because the activity (Vmax) of ALA dehydrase in most mammalian tissues is 20-100 times higher than that of ALA synthase or PBG deaminase (3, 24) , it is often thought that activity of the dehydrase rarely limits the rate of heme synthesis (24) . We show that a 50-70% decrease in ALA dehydrase has only a small effect on hepatic heme synthesis when measured in vitro (Fig. 3) . However, larger decreases in ALA dehydrase affects heme synthesis drastically (Fig. 3) . Furthermore, the effect of a decrease in dehydrase activity on heme synthesis from ALA depends on the initial concentration of ALA (Table III) since this will affect the rate of accumulation of PBG. Therefore, during iron loading, the in vivo activity of ALA dehydrase can decrease the concentration of PBG sufficiently to decrease the rate of conversion of ALA to heme. Despite the decrease in the Vmax of ALA dehydrase, restoration of a normal rate of heme synthesis remains possible if the rate of PBG formation is sufficient. This condition may be met because we found that iron loading led to an increase of ALA synthase (Fig. 2, ref. 1) , and probably to an increase in the hepatic concentration of ALA.
The effect of decreased activity of ALA dehydrase on heme synthesis in vivo is further complicated since ALA and PBG can leak out of hepatocytes, especially when hepatic production and accumulation are increased. This leakage occurs in human acute porphyrias, in certain experimental porphyrias (3, 5) and in cultured liver cells (25) . Because leakage of ALA evidently occurs at concentrations well below the Km of ALA dehydrase, this loss of substrate may enhance the effect of a decrease in ALA dehydrase in decreasing heme synthesis. Because the Km of the dehydrase is so much higher than that of PBG deaminase, leakage of ALA probably affects heme synthesis more than does leakage of PBG.
Separate actions of iron to decrease ALA dehydrase and to potentiate drug-mediated induction of ALA synthase. Our studies with iron-dextran and AIA show that treatment with iron-dextran potentiates the induction of ALA synthase produced by AIA as early as 4 h after treatment (Fig. 4a) , before the iron-mediated decrease in activity of ALA dehydrase occurred (Fig. 4b) . In fact, simultaneous treatment with AIA and iron-dextran virtually abolished the decrease in activity of ALA dehydrase caused by iron-dextran alone ( Fig. 4b; 18-h time point) . The explanation for this protection is unknown, but may be due to substrate stabilization due to the increased ALA synthase (Fig.  4) . It is not due to a decrease in hepatic iron uptake in rats treated with both AIA and iron-dextran since hepatic iron concentrations in such rats are similar to those in rats given iron-dextran alone (results not shown). These results demonstrate that the potentiation of induction of ALA-synthase following administration of iron and AIA, is not mediated by a decrease in ALA-dehydrase.
